Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A5402
PACTR202509535170698Phase 2Not yet recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of escitalopram and pramipexole, sponsored by National Institute of Allergy and Infectious Diseases. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
escitaloprampramipexole
Beyond the preview
Go deeper on PACTR202509535170698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509535170698.